{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:00:57Z","timestamp":1791928857369,"version":"4.3.4"},"reference-count":90,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"15","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2025,12,3]]},"DOI":"10.1167\/iovs.66.15.16","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T14:00:37Z","timestamp":1764770437000},"page":"16","source":"Crossref","is-referenced-by-count":3,"title":["Effect of Dipyridamole on Experimental Autoimmune Uveitis: Reprogrammed Immune Cell Landscape and Reduced Th17 Pathogenicity"],"prefix":"10.1167","volume":"66","author":[{"given":"Binyao","family":"Chen","sequence":"first","affiliation":[{"name":"Zhongshan Ophthalmic Center, Sun Yat-Sen University, WHO Collaborating Centre for Eye Care and Vision, State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohao","family":"Huang","sequence":"additional","affiliation":[{"name":"Guangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China"},{"name":"Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Chen","sequence":"additional","affiliation":[{"name":"Zhongshan Ophthalmic Center, Sun Yat-Sen University, WHO Collaborating Centre for Eye Care and Vision, State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wu","sequence":"additional","affiliation":[{"name":"Guangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China"},{"name":"Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjie","family":"Lv","sequence":"additional","affiliation":[{"name":"Zhongshan Ophthalmic Center, Sun Yat-Sen University, WHO Collaborating Centre for Eye Care and Vision, State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Wen","sequence":"additional","affiliation":[{"name":"Bengbu Medical University, Bengbu, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohang","family":"Wu","sequence":"additional","affiliation":[{"name":"Zhongshan Ophthalmic Center, Sun Yat-Sen University, WHO Collaborating Centre for Eye Care and Vision, State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xulin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhongshan Ophthalmic Center, Sun Yat-Sen University, WHO Collaborating Centre for Eye Care and Vision, State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Lin","sequence":"additional","affiliation":[{"name":"Zhongshan Ophthalmic Center, Sun Yat-Sen University, WHO Collaborating Centre for Eye Care and Vision, State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"},{"name":"Hainan Eye Hospital and Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Haikou, Hainan, China"},{"name":"Center for Precision Medicine and Department of Genetics and Biomedical Informatics, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenru","family":"Su","sequence":"additional","affiliation":[{"name":"Zhongshan Ophthalmic Center, Sun Yat-Sen University, WHO Collaborating Centre for Eye Care and Vision, State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"},{"name":"Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"705","DOI":"10.5301\/ejo.5000278","article-title":"Review on the worldwide epidemiology of uveitis","volume":"23","author":"Miserocchi","year":"2013","journal-title":"Eur J Ophthalmol"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.preteyeres.2011.06.005","article-title":"Understanding uveitis: the impact of research on visual outcomes","volume":"30","author":"De Smet","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s10238-022-00954-6","article-title":"Pathogenesis and current therapies for non-infectious uveitis","volume":"23","author":"Wu","year":"2023","journal-title":"Clin Exp Med"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","article-title":"A focus on the epidemiology of uveitis","volume":"26","author":"Tsirouki","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"101216","DOI":"10.1016\/j.preteyeres.2023.101216","article-title":"Risk factors, clinical features and treatment of Beh\u00e7et's disease uveitis","volume":"97","author":"Zhong","year":"2023","journal-title":"Prog Retin Eye Res"},{"issue":"5-6","key":"bib6","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3109\/08820538.2014.959203","article-title":"Side-effects of anti-inflammatory therapy in uveitis","volume":"29","author":"Uchiyama","year":"2014","journal-title":"Semin Ophthalmol"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1136\/bjo.2007.123554","article-title":"Ocular features of Behcet's disease: an international collaborative study","volume":"91","author":"Kitaichi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3109\/08830185.2012.747524","article-title":"Uveitis in Mouse and Man","volume":"32","author":"Forrester","year":"2013","journal-title":"Int Rev Immunol"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12974-024-03096-6","article-title":"Beneficial mechanisms of dimethyl fumarate in autoimmune uveitis: insights from single-cell RNA sequencing","volume":"21","author":"Zhu","year":"2024","journal-title":"J Neuroinflamm"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s13238-021-00882-3","article-title":"Aging weakens Th17 cell pathogenicity and ameliorates experimental autoimmune uveitis in mice","volume":"13","author":"Li","year":"2022","journal-title":"Protein Cell"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1167\/iovs.17-22850","article-title":"Active lymphatic drainage from the eye measured by noninvasive photoacoustic imaging of near-infrared nanoparticles","volume":"59","author":"Y\u00fccel","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"8862","DOI":"10.1167\/iovs.11-8153","article-title":"Following EAU recovery there is an associated MC5r-dependent APC induction of regulatory immunity in the spleen","volume":"52","author":"Lee","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1172\/JCI42440","article-title":"A look at autoimmunity and inflammation in the eye","volume":"120","author":"Caspi","year":"2010","journal-title":"J Clin Invest"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1089\/jir.2011.0042","article-title":"Cytokines in autoimmune uveitis","volume":"31","author":"Horai","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.autrev.2016.09.001","article-title":"Dry eye disease and uveitis: a closer look at immune mechanisms in animal models of two ocular autoimmune diseases","volume":"15","author":"Bose","year":"2016","journal-title":"Autoimmun Rev"},{"key":"bib16","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1056\/NEJM198705143162005","article-title":"Dipyridamole","volume":"316","author":"FitzGerald","year":"1987","journal-title":"N Engl J Med"},{"issue":"3","key":"bib17","doi-asserted-by":"publisher","first-page":"s39","DOI":"10.1161\/ATVBAHA.107.160226","article-title":"Translational therapeutics of dipyridamole","volume":"28","author":"Kim","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.phrs.2014.05.008","article-title":"Classical and pleiotropic actions of dipyridamole: not enough light to illuminate the dark tunnel?","volume":"87","author":"Balakumar","year":"2014","journal-title":"Pharmacol Res"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"822","DOI":"10.2174\/1568026615666150220111942","article-title":"Dipyridamole: a drug with unrecognized antioxidant activity","volume":"15","author":"Ciacciarelli","year":"2015","journal-title":"Curr Top Med Chem"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3390\/cells8040323","article-title":"The potential use of metformin, dipyridamole, N-acetylcysteine and statins as adjunctive therapy for systemic lupus erythematosus","volume":"8","author":"Tan","year":"2019","journal-title":"Cells"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3389\/fimmu.2016.00315","article-title":"Cyclic AMP represents a crucial component of Treg cell-mediated immune regulation","volume":"7","author":"Klein","year":"2016","journal-title":"Front Immunol"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1741-7015-11-96","article-title":"Phosphodiesterase 4-targeted treatments for autoimmune diseases","volume":"11","author":"Kumar","year":"2013","journal-title":"BMC Med"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1161\/01.CIR.0000154607.90506.45","article-title":"Dipyridamole selectively inhibits inflammatory gene expression in platelet\u2013monocyte aggregates","volume":"111","author":"Weyrich","year":"2005","journal-title":"Circulation"},{"key":"bib24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1160\/TH12-05-0326","article-title":"Dipyridamole decreases inflammatory metalloproteinase-9 expression and release by human monocytes","volume":"109","author":"Massaro","year":"2013","journal-title":"Thromb Haemost"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1186\/1742-2094-10-89","article-title":"Reduction of microglial activity in a model of multiple sclerosis by dipyridamole","volume":"10","author":"Sloka","year":"2013","journal-title":"J Neuroinflamm"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.intimp.2010.08.006","article-title":"Influence of dipyridamole and its combination with NO donor or NO synthase inhibitor on adjuvant arthritis","volume":"10","author":"Gomaa","year":"2010","journal-title":"Int Immunopharmacol"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.cell.2019.10.027","article-title":"Mucosal profiling of pediatric-onset colitis and ibd reveals common pathogenics and therapeutic pathways","volume":"179","author":"Huang","year":"2019","journal-title":"Cell"},{"issue":"8697","key":"bib28","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/0140-6736(90)92643-V","article-title":"Criteria for diagnosis of Behcet's disease","volume":"335","author":"Internationalstudygroupforbehc","year":"1990","journal-title":"Lancet"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jare.2024.07.029","article-title":"Histone deacetylases facilitate Th17-cell differentiation and pathogenicity in autoimmune uveitis via CDK6\/ID2 axis","volume":"72","author":"Zhang","year":"2025","journal-title":"J Adv Res"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.pharmthera.2005.07.003","article-title":"Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents","volume":"109","author":"Lugnier","year":"2006","journal-title":"Pharmacol Ther"},{"issue":"2","key":"bib33","doi-asserted-by":"publisher","first-page":"e1133","DOI":"10.1212\/NXI.0000000000001133","article-title":"Progranulin suppressed autoimmune uveitis and autoimmune neuroinflammation by inhibiting Th1\/Th17 cells and promoting Treg cells and M2 macrophages","volume":"9","author":"Wang","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"12","key":"bib34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1167\/iovs.64.12.28","article-title":"Therapeutic effects of upadacitinib on experimental autoimmune uveitis: insights from single-cell analysis","volume":"64","author":"Huang","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/ni.2031","article-title":"The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF","volume":"12","author":"El-Behi","year":"2011","journal-title":"Nat Immunol"},{"issue":"1","key":"bib36","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1038\/s41467-022-33502-7","article-title":"Multicellular immune dynamics implicate PIM1 as a potential therapeutic target for uveitis","volume":"13","author":"Li","year":"2022","journal-title":"Nat Commun"},{"issue":"11","key":"bib37","doi-asserted-by":"publisher","first-page":"109682","DOI":"10.1016\/j.celrep.2021.109682","article-title":"RORa is critical for mTORC1 activity in T cell-mediated colitis","volume":"36","author":"Chi","year":"2021","journal-title":"Cell Rep"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jaut.2012.07.010","article-title":"A comprehensive review of the phenotype and function of antigen-specific immunoregulatory double negative T cells","volume":"40","author":"Hillhouse","year":"2013","journal-title":"J Autoimmun"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.4049\/jimmunol.1500849","article-title":"Foxo1 is a T cell-intrinsic inhibitor of the ROR?t-Th17 program","volume":"195","author":"Lain\u00e9","year":"2015","journal-title":"J Immunol"},{"issue":"1","key":"bib40","doi-asserted-by":"publisher","first-page":"8398","DOI":"10.1038\/s41598-022-12594-7","article-title":"PCBP1 is associated with rheumatoid arthritis by affecting RNA products of genes involved in immune response in Th1 cells","volume":"12","author":"Cao","year":"2022","journal-title":"Sci Rep"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.2353\/ajpath.2006.051069","article-title":"Uncoupling protein 2 has protective function during experimental autoimmune encephalomyelitis","volume":"168","author":"Vogler","year":"2006","journal-title":"Am J Pathol"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41590-024-01804-1","article-title":"JAK-STAT signaling maintains homeostasis in T cells and macrophages","volume":"25","author":"Fortelny","year":"2024","journal-title":"Nat Immunol"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/intimm\/dxn002","article-title":"STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells","volume":"20","author":"Passerini","year":"2008","journal-title":"Int Immunol"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jaci.2012.07.032","article-title":"Inhibition of Pim1 kinase prevents peanut allergy by enhancing Runx3 expression and suppressing TH2 and TH17 T-cell differentiation","volume":"130","author":"Wang","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"3 Suppl 3","key":"bib46","first-page":"S17","article-title":"Dipyridamole trials in stroke prevention","volume":"51","author":"Diener","year":"1998","journal-title":"Neurology"},{"issue":"7599","key":"bib47","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1136\/bmj.39160.702188.AD","article-title":"Dipyridamole with aspirin is better than aspirin alone in preventing vascular events after ischaemic stroke or TIA","volume":"334","author":"Sudlow","year":"2007","journal-title":"BMJ"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1365-2125.1987.tb03194.x","article-title":"Dipyridamole: pharmacokinetics and effects on aspects of platelet function in man","volume":"24","author":"Gregov","year":"1987","journal-title":"Br J Clin Pharmacol"},{"key":"bib49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0049-3848(83)90356-0","article-title":"Mechanism of action of dipyridamole","volume":"4","author":"Harker","year":"1983","journal-title":"Thromb Res Suppl"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.chembiol.2020.10.003","article-title":"Dipyridamole inhibits lipogenic gene expression by retaining SCAP-SREBP in the endoplasmic reticulum","volume":"28","author":"Esquejo","year":"2021","journal-title":"Cell Chem Biol"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/01.CIR.101.6.624","article-title":"Antiarrhythmic efficacy of dipyridamole in treatment of reperfusion arrhythmias?: evidence for cAMP-mediated triggered activity as a mechanism responsible for reperfusion arrhythmias","volume":"101","author":"Yoshida","year":"2000","journal-title":"Circulation"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1038\/s41467-019-09801-x","article-title":"Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome","volume":"10","author":"Ali","year":"2019","journal-title":"Nat Commun"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"110051","DOI":"10.1016\/j.mehy.2020.110051","article-title":"Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole","volume":"143","author":"DiNicolantonio","year":"2020","journal-title":"Med Hypotheses"},{"issue":"6","key":"bib54","doi-asserted-by":"publisher","first-page":"R289","DOI":"10.1186\/cc10576","article-title":"Dipyridamole augments the antiinflammatory response during human endotoxemia","volume":"15","author":"Ramakers","year":"2011","journal-title":"Crit Care"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1093\/infdis\/jiz344","article-title":"A randomized, placebo-controlled, pilot clinical trial of dipyridamole to decrease human immunodeficiency virus-associated chronic inflammation","volume":"221","author":"Macatangay","year":"2020","journal-title":"J Infect Dis"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","article-title":"Expression of ectonucleotidase CD39 by Foxp3+ treg cells: hydrolysis of extracellular ATP and immune suppression","volume":"110","author":"Borsellino","year":"2007","journal-title":"Blood"},{"issue":"39","key":"bib57","doi-asserted-by":"publisher","first-page":"e2316161121","DOI":"10.1073\/pnas.2316161121","article-title":"Transcription factor EGR2 alleviates autoimmune uveitis via activation of GDF15 to modulate the retinal microglial phenotype","volume":"121","author":"Li","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1007\/s10753-024-02149-5","article-title":"Irisin alleviates autoimmune uveitis through promoting retinal microglial M1 to M2 phenotypic polarization mediated by HIF-1a pathway","volume":"48","author":"Wang","year":"2025","journal-title":"Inflammation"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1517\/13543776.2014.968127","article-title":"cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseases","volume":"24","author":"Martinez","year":"2014","journal-title":"Expert Opin Ther Pat"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"105030","DOI":"10.1016\/j.phrs.2020.105030","article-title":"Blame the signaling: Role of cAMP for the resolution of inflammation","volume":"159","author":"Tavares","year":"2020","journal-title":"Pharmacol Res"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1096\/fj.99-0508com","article-title":"Adenosine inhibits IL-12 and TNF-a production via adenosine A2a\u00a0receptor-dependent and independent mechanisms","volume":"14","author":"Hasko","year":"2000","journal-title":"FASEB J"},{"issue":"193","key":"bib62","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-3-540-89615-9_8","article-title":"Adenosine receptors and inflammation","author":"Blackburn","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.it.2009.04.001","article-title":"A(2B) adenosine receptors in immunity and inflammation","volume":"30","author":"Hask\u00f3","year":"2009","journal-title":"Trends Immunol"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3389\/fimmu.2016.00222","article-title":"Molecular mechanisms for cAMP-mediated immunoregulation in T cells\u2014role of anchored protein kinase A signaling units","volume":"7","author":"Wehbi","year":"2016","journal-title":"Front Immunol"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.tibs.2024.01.004","article-title":"cAMP signaling: a remarkably regional affair","volume":"49","author":"Bock","year":"2024","journal-title":"Trends Biochem Sci"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3390\/cells11020308","article-title":"Emerging role of cAMP\/AMPK signaling","volume":"11","author":"Aslam","year":"2022","journal-title":"Cells"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.immuni.2008.03.002","article-title":"Cytokine signaling modules in inflammatory responses","volume":"28","author":"O'Shea","year":"2008","journal-title":"Immunity"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.immuni.2007.02.009","article-title":"Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation","volume":"26","author":"Laurence","year":"2007","journal-title":"Immunity"},{"issue":"5155","key":"bib69","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1126\/science.8140422","article-title":"Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6","volume":"264","author":"Zhong","year":"1994","journal-title":"Science"},{"key":"bib70","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1749-6632.2009.04911.x","article-title":"Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?","volume":"1171","author":"Aggarwal","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"bib71","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","article-title":"T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma","volume":"28","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"bib72","doi-asserted-by":"publisher","first-page":"6070","DOI":"10.4049\/jimmunol.180.9.6070","article-title":"Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases","volume":"180","author":"Liu","year":"2008","journal-title":"J Immunol"},{"issue":"7188","key":"bib73","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"key":"bib74","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.immuni.2012.03.014","article-title":"JAK and STAT signaling molecules in immunoregulation and immune-mediated disease","volume":"36","author":"O'Shea","year":"2012","journal-title":"Immunity"},{"issue":"1","key":"bib75","doi-asserted-by":"publisher","first-page":"e24134","DOI":"10.4161\/jkst.24134","article-title":"Therapeutic targeting of STAT pathways in CNS autoimmune diseases","volume":"2","author":"Egwuagu","year":"2013","journal-title":"JAK-STAT"},{"key":"bib76","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cellsig.2015.10.009","article-title":"cAMP\/PKA enhances interleukin-1\u00df-induced interleukin-6 synthesis through STAT3 in glial cells","volume":"28","author":"Tanabe","year":"2016","journal-title":"Cell Signal"},{"key":"bib77","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1038\/onc.2017.38","article-title":"The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP\u2013PKA\u2013EGFR\u2013STAT3 axis","volume":"36","author":"Zhou","year":"2017","journal-title":"Oncogene"},{"key":"bib78","doi-asserted-by":"publisher","first-page":"9499","DOI":"10.1073\/pnas.93.18.9499","article-title":"Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways","volume":"93","author":"Sengupta","year":"1996","journal-title":"Proc Natl Acad Sci"},{"key":"bib79","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.canlet.2013.02.042","article-title":"Death of multiple myeloma cells induced by cAMP-signaling involves downregulation of Mcl-1 via the JAK\/STAT pathway","volume":"335","author":"Follin-Arbelet","year":"2013","journal-title":"Cancer Lett"},{"key":"bib80","doi-asserted-by":"publisher","first-page":"113469","DOI":"10.1016\/j.celrep.2023.113469","article-title":"PIM kinases regulate early human Th17 cell differentiation","volume":"42","author":"Buchacher","year":"2023","journal-title":"Cell Rep"},{"issue":"7","key":"bib81","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s12032-022-01675-2","article-title":"PIM1\/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer","volume":"39","author":"Mahata","year":"2022","journal-title":"Med Oncol"},{"key":"bib82","doi-asserted-by":"publisher","first-page":"1443784","DOI":"10.3389\/fimmu.2024.1443784","article-title":"PIM1 signaling in immunoinflammatory diseases: an emerging therapeutic target","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"key":"bib83","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/art.40863","article-title":"Pim-1 as a therapeutic target in lupus nephritis","volume":"71","author":"Fu","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"bib84","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12974-023-02829-3","article-title":"Progesterone attenuates Th17-cell pathogenicity in autoimmune uveitis via Id2\/Pim1 axis","volume":"20","author":"Liu","year":"2023","journal-title":"J Neuroinflamm"},{"key":"bib85","first-page":"645","article-title":"The bioavailability of dipyridamole in the form of liposomes","volume":"41","author":"Stozek","year":"1986","journal-title":"Pharmazie"},{"key":"bib86","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1071-3581(05)80003-0","article-title":"Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study","volume":"2","author":"Lette","year":"1995","journal-title":"J Nucl Cardiol"},{"issue":"3","key":"bib87","first-page":"CD001820","article-title":"Dipyridamole for preventing stroke and other vascular events in patients with vascular disease","author":"De Schryver","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"bib88","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1159\/000521083","article-title":"Effects of dose titration on dipyridamole-induced headache: a randomized, double-blind clinical trial","volume":"51","author":"Kang","year":"2022","journal-title":"Cerebrovasc Dis"},{"key":"bib89","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1468-2982.2006.01137.x","article-title":"Dipyridamole may induce migraine in patients with migraine without aura","volume":"26","author":"Kruuse","year":"2006","journal-title":"Cephalalgia"},{"key":"bib90","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4274\/mirt.galenos.2022.72593","article-title":"Comparison of regadenoson and dipyridamole safety profiles during stress myocardial perfusion imaging","volume":"32","author":"Roczniak","year":"2023","journal-title":"Mol Imaging Radionucl Ther"},{"key":"bib30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/978-1-60761-720-4_22","article-title":"Rodent models of experimental autoimmune uveitis","volume-title":"Autoimmunity: Methods and Protocols","author":"Agarwal","year":"2012"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2811180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:58Z","timestamp":1791927118000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2811180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":90,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.15.16","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,3]]}}}